Date: Oct 18, 2011 Source: DOC (
click here to go to the source)
Oct. 18, 2011: DiaCarta signed sales contracts during US Biotech Trade Mission in China.
BEIJING - U.S. Commerce Under Secretary for International Trade Francisco Sanchez witnessed today the signing of a $2 million sales agreement for an American bio-tech company - and trade mission participant - to sell its cervical cancer testing products in China. The agreement is expected to increase U.S. exports and create more American jobs. Sanchez is in Beijing on the first leg of his trade mission to China where he is leading 19 U.S. companies to explore opportunities in China's biotechnology industry.
The deal was finalized on the trade mission between California-based DiaCarta, and Kodia Biotechnology, Co., Ltd. Kodia is a joint venture between DiaCarta and Kelong Medical Apparatus & Instruments Co., Ltd., of Henan, China.
"China's biotech sector is growing at roughly 25 percent a year, so it makes sense to bring the products and services of U.S. companies to China to help meet the demand," Sanchez said. "This deal is a great example of the incredible potential that exists when the United States and China come together. This sale will not only help an American company prosper and hire more people, but it will also help China benefit from world class, cutting-edge American technology."
